Fig. 4From: An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimodChanges in normalized gene expression of CCR2 in the skin. The mean fold reduction was 0.59 (p = 0.019) (shown in red) after 8 weeks of treatmentBack to article page